German Stock News

XTRA:ENR
XTRA:ENRElectrical

Siemens Energy’s US$1 Billion US Grid Push and Gamesa Options Might Change The Case For Investing In Siemens Energy (XTRA:ENR)

In early February 2026, Siemens Energy said it will invest US$1 billion over two years to expand US manufacturing of grid equipment and gas turbines, while its CEO acknowledged activist calls for a potential spin-off of the loss-making Siemens Gamesa wind unit once a clear path to profitability is established. Alongside this, Siemens Energy highlighted record order intake, a return to profitability with dividend reinstatement, and a turnaround plan targeting double-digit margins at Siemens...
XTRA:PAH3
XTRA:PAH3Auto

Porsche’s Potential 718 EV Pullback Might Change The Case For Investing In Porsche (XTRA:PAH3)

Porsche Automobil Holding has reportedly reconsidered its electric vehicle rollout, with new CEO Michael Leiters weighing whether to scrap the planned 718 electric Boxster and Cayman models after development delays and cost overruns, as of early February 2026. This potential pullback highlights how weaker demand in China and the high cost of reversing earlier EV commitments are forcing Porsche to re‑prioritize where and how it spends on future technologies. We’ll now examine how this...
XTRA:LHA
XTRA:LHAAirlines

Should Pre-Earnings Demand Strength at Lufthansa (XTRA:LHA) Require Action From Investors?

Deutsche Lufthansa AG has recently seen elevated pre-market trading activity on XETRA, as investors react to strong seasonal ticket demand, resilient cargo operations, and heightened attention ahead of its scheduled earnings release on 6 March 2026. This combination of seasonal passenger trends and cargo momentum is sharpening focus on how the airline balances growth ambitions with its existing leverage and capital expenditure requirements. Against this backdrop of strong seasonal demand, we...
DB:0QM
DB:0QMHospitality

European Penny Stocks To Watch In February 2026

As the European market shows signs of modest recovery, with the pan-European STOXX Europe 600 Index gaining 0.44% amidst mixed performances across major indices, investors are cautiously optimistic about future growth prospects. In such a climate, penny stocks—though an outdated term—remain relevant as they often represent smaller or newer companies that can offer unique investment opportunities. These stocks, when backed by strong fundamentals and financial resilience, present potential for...
XTRA:ADS
XTRA:ADSLuxury

adidas (XTRA:ADS) Is Up 5.1% After €1 Billion Buyback And All-Star Push With Anthony Edwards – Has The Bull Case Changed?

In late January 2026, adidas AG announced a share repurchase program of up to €1,000 million, to be financed by its anticipated 2026 cash flows, with all repurchased shares intended for cancellation by the end of the program’s validity in 2026. Around the same time, adidas also ramped up brand visibility with a bold All-Star 2026 campaign featuring Anthony Edwards and an upcoming “All-Star” sneaker release, underlining its push to deepen engagement with basketball consumers. Next, we’ll look...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Technologies (XTRA:IFX) Margin Compression In Q1 2026 Tests Bullish Growth Narratives

Infineon Technologies (XTRA:IFX) opened its 2026 financial year with Q1 revenue of €3.7b and basic EPS of €0.20, as investors weighed the latest quarterly print against a year of compressed profitability and one off effects. The company has seen quarterly revenue move from €3.9b in Q4 2024 to €3.9b in Q4 2025 and then €3.7b in Q1 2026, while basic EPS shifted from €0.29 in Q4 2024 to €0.18 in Q4 2025 and €0.20 in the latest quarter. This sets up a story where revenue resilience meets pressure...
XTRA:AFX
XTRA:AFXMedical Equipment

Assessing Carl Zeiss Meditec (XTRA:AFX) Valuation After ARTEVO Microscope Approval In China

Why the ARTEVO approval in China matters for Carl Zeiss Meditec (XTRA:AFX) Carl Zeiss Meditec (XTRA:AFX) just received clearance from China’s National Medical Products Administration for its ARTEVO 750 and ARTEVO 850 ophthalmic microscopes, expanding its surgical portfolio access in one of the world’s largest healthcare markets. See our latest analysis for Carl Zeiss Meditec. Despite the positive headline from the ARTEVO approvals in China, Carl Zeiss Meditec’s recent 30 day share price...
XTRA:BMW
XTRA:BMWAuto

BMW’s New Long-Term ZF Transmission Deal Could Be A Game Changer For Bayerische Motoren Werke (XTRA:BMW)

BMW Group has signed a multibillion-euro long-term agreement with ZF Friedrichshafen AG to supply and further develop 8-speed automatic transmissions for its passenger cars, with the contract running until the late 2030s to support future drive concepts and lower-emission mobility. Alongside this, BMW has reshaped its global sales leadership, most recently appointing new regional heads for China, Germany and Latin America, which, together with the secured transmission supply, underlines how...
XTRA:MBG
XTRA:MBGAuto

Can Microsoft’s F1 Partnership Reframe Mercedes-Benz Group’s (XTRA:MBG) Edge in Data-Driven Performance?

In January 2026, Microsoft and the Mercedes-AMG PETRONAS F1 Team announced a multiyear partnership to embed Microsoft's technologies into race operations, aiming to boost efficiency, innovation and on-track performance for the globally followed Formula 1 outfit. By placing cloud, data and AI tools at the center of an elite motorsport program, the collaboration highlights how advanced technology is increasingly shaping both competitive outcomes and fan engagement in global sports franchises...
XTRA:RDC
XTRA:RDCConsumer Retailing

Did gematik’s PoPP E‑Prescription Specs Just Reshape Redcare Pharmacy's (XTRA:RDC) Digital Moat Narrative?

In January 2026, Redcare Pharmacy reported that Germany’s digital health agency gematik had issued draft PoPP specifications confirming continued support for smooth e-prescription redemption via the Shop Apotheke app, while phasing out the older CardLink-based VSDM++ process. The planned PoPP rollout not only maintains low-friction e-prescription use but also raises data security and introduces flexible, software-based authentication that could strengthen Redcare’s position in Germany’s...
XTRA:SAP
XTRA:SAPSoftware

Assessing SAP (XTRA:SAP) Valuation After A Period Of Weak Share Price Performance

Recent performance snapshot for SAP (XTRA:SAP) SAP (XTRA:SAP) has drawn fresh attention after a period of weaker share performance, with the stock showing negative returns over the past month, past 3 months, year to date, and the past year. See our latest analysis for SAP. With the share price now at €166.82 after a 1 month share price return of a 19.10% decline and a 1 year total shareholder return of a 37.84% decline, recent momentum looks weak compared with SAP’s stronger 3 and 5 year...
XTRA:M8G
XTRA:M8GMedia

Is Verve Group (XTRA:M8G) Rebrand Enough To Clarify Its Data‑Driven Advertising Strategy?

In late January 2026, Verve Group SE introduced “Verve For Advertisers,” a unified US brand that combines Jun Group and Captify capabilities, and issued conservative 2026 revenue guidance of €680 million to €730 million while also presenting at Oppenheimer’s 11th Annual Emerging Growth Conference on 3 February 2026. This combination of a consolidated advertiser offering and explicit full-year guidance highlights Verve’s focus on integrating its data and AI-driven ad solutions under a...
HMSE:B4B
HMSE:B4BConsumer Retailing

Is Metro (HMSE:B4B) Offering Value After Recent Tight Trading Range?

If you are wondering whether Metro at €5.85 is offering value or a value trap, this article walks through what the numbers are actually saying about the stock. Over the short term, Metro has had a 1.7% decline over the last 7 days, while the 30 day return and year to date return both sit at 2.3%. This may signal shifting views on its risk and reward profile. Recent coverage around Metro has focused on its position in the consumer retailing space and how investors are weighing its exposure to...
XTRA:P911
XTRA:P911Auto

Porsche (XTRA:P911) Valuation Check As Electric 718 Rethink Signals A Shift In EV Strategy

Dr. Ing. h.c. F. Porsche (XTRA:P911) is in focus after reports that management is reassessing electric 718 Boxster and Cayman plans, while a new Head of Design arrives from McLaren in early 2026. See our latest analysis for Dr. Ing. h.c. F. Porsche. Those design changes and the rethink on electric 718 models are coming at a weaker moment for the stock, with a 1 month share price return of 16.39% and a 1 year total shareholder return of 30.16%, pointing to fading momentum after earlier...
DB:3KT
DB:3KTHealthcare Services

European Penny Stocks With Market Caps Below €8M

As Europe experiences a modest economic recovery, with the pan-European STOXX Europe 600 Index ending slightly higher, investors are increasingly optimistic despite ongoing trade and geopolitical concerns. For those willing to explore beyond the well-known market leaders, penny stocks present intriguing possibilities. While the term 'penny stocks' might seem outdated, these smaller or newer companies continue to offer potential growth at accessible price points when backed by robust...
XTRA:HYQ
XTRA:HYQDiversified Financial

European Insider-Owned Growth Stocks For February 2026

As the eurozone economy continues its modest recovery, with confidence strengthening across most sectors, European markets are displaying a mix of optimism and caution amid geopolitical concerns. In this environment, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as they often signal strong confidence from those closest to the business.
XTRA:SRT3
XTRA:SRT3Life Sciences

A Look At Sartorius (XTRA:SRT3) Valuation After Earnings Reveal Margin Pressure And Cautious Guidance

Sartorius (XTRA:SRT3) is back in focus after its latest earnings release highlighted margin compression and higher operating costs. Management issued cautious guidance that has sharpened investor attention on near term profitability. See our latest analysis for Sartorius. The latest earnings setback has arrived after a mixed stretch for shareholders, with an 11.95% 90 day share price return contrasting with a 1 year total shareholder return decline of 4.14% and a 5 year total shareholder...